Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; the previous funding-status notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:56:57.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a site-wide notice about government funding and operating status, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:34:08.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated various metadata labels related to results posting and QC criteria (e.g., Results First Posted, Last Update Posted, Last Update Submitted that Met QC Criteria, No FEAR Act Data). The revision tag changed from v3.3.4 to v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T04:28:50.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this appears to be an administrative update with no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:57:28.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    A new Locations section is added showing the Chicago, Illinois site; the standalone Illinois Locations entry was removed, and the revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:09:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.